Loading provider…
Loading provider…
Urology Physician in Los Angeles, CA
NPI: 1063510840Primary Employer
Tower Urology Inc
towerurology.com
HQ Phone
Get MD David's Phone Numberphone_androidMobile
Get MD David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
2001 - 2026
CA State Medical License

American Board of Urology
Urology

National Board of Physicians and Surgeons
Urology
University of Southern California/Los Angeles General Medical Center (USC/LA General)
Residency • Urology
Until 2005
Residency • Surgery
1999 - 2001
Albert Einstein College of Medicine
einsteinmed.edu
Medical School
Until 1999
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 1,039 | 1,717 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 772 | 1,153 |
| 3 | 84153PSA (prostate specific antigen) measurement | 736 | 1,101 |
| 4 | 84403Testosterone (hormone) level | 730 | 1,085 |
| 5 | 80069Kidney function blood test panel | 636 | 885 |
Authors: Jonathan Eandi
Journal: J Endourol
Diagnostic Performance and Safety of Positron Emission Tomography withF-rhPSMA-7.3 in Patients with Newly Diagnosed Unfavourable Intermediate- to Very-high-risk Prosta...
Authors: Devaki Shilpa Surasi, Matthias Eiber, Tobias Maurer, Mark A Preston, Brian T Helfand
Lead Sponsor: Lipac Oncology LLC
Collaborators: TesoRx Pharma, LLC
Intervention / Treatment: DRUG: TSD-001
Lead Sponsor: Clarity Pharmaceuticals Ltd
Intervention / Treatment: DRUG: 64Cu-SAR-bisPSMA
Lead Sponsor: Veru Inc.
Intervention / Treatment: DRUG: VERU-111, DRUG: Enzalutamide, Abiraterone